Zevalin

In the US, Zevalin (ibritumomab systemic) is a member of the following drug classes: CD20 monoclonal antibodies, radiologic conjugating agents and is used to treat Non-Hodgkin's Lymphoma.

US matches:

• Zevalin In-111


• Zevalin Y-90


• Zevalin

UK matches:

• Zevalin 1.6 mg/ml, Kit for radiopharmaceutical preparation for infusion (SPC)

Ingredient matches for Zevalin

Ibritumomab

Ibritumomab Tiuxetan is reported as an ingredient of Zevalin in the following countries:

• Austria


• Belgium


• Canada


• Croatia (Hrvatska)


• Finland


• France


• Germany


• Hungary


• Ireland


• Israel


• Italy


• Luxembourg


• Netherlands


• Norway


• Poland


• Romania


• Slovenia


• South Africa


• Sweden


• Switzerland


• Turkey


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.